On today's episode Spencer and Dennis discuss JAB's acquisition of PNRA, AMZN's recent 7-day closing streak, and the latest ADP jobs numbers. Later the hosts get stock forecasts from the President of research firm ValuEngine and learn the methodology used by a veteran technical analyst and educator. Closing the show, biotech Adam Feuerstein elaborates on why he claims the valuations in CYCC and many small-cap biotechs are fundamentally sketchy.
Paul Henneman, President of ValuEngine (14:45)
Hima Reddy, CMT Content Director at John Wiley and Sons (32:50)
Adam Feuerstein, Senior Columnist at The Street (46:50)
Listen to PreMarket Prep and chat LIVE with hosts, guests, and other listeners every weekday morning from 8-9 ET!